Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strains

Dig Dis Sci. 2004 Feb;49(2):300-3. doi: 10.1023/b:ddas.0000017455.39171.56.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • DNA, Viral / metabolism
  • Drug Resistance
  • Hepatitis B / drug therapy*
  • Hepatitis B / virology
  • Hepatitis B virus / drug effects*
  • Hepatitis B virus / genetics
  • Humans
  • Lamivudine / therapeutic use*
  • Liver Failure / drug therapy*
  • Liver Failure / virology*
  • Male
  • Middle Aged
  • Organophosphonates*
  • Retreatment
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Treatment Outcome

Substances

  • Antiviral Agents
  • DNA, Viral
  • Organophosphonates
  • Reverse Transcriptase Inhibitors
  • Lamivudine
  • Adenine
  • adefovir dipivoxil